Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norris

Showing results (511-520 of 532) with videos related to

Pageof 54
Sort By:
Cell Reports|October 24, 2019
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast CancerKimberly J Cocce, Jeff S Jasper, Taylor K Desautels, et al.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Nature Communications|November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Science Advances|March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Cancers|April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood NeuroblastomaLaura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Oncogene|January 24, 2019
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunctionKlaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, et al.
Pageof 54

Showing results (511-520 of 532) with videos related to

Sort By:
Pageof 54
Cell Reports|October 24, 2019
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast CancerKimberly J Cocce, Jeff S Jasper, Taylor K Desautels, et al.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Nature Communications|November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Science Advances|March 3, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Cancers|April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood NeuroblastomaLaura D Gamble, Stefania Purgato, Michelle J Henderson, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Oncogene|January 24, 2019
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunctionKlaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, et al.
Pageof 54